Table 1

Characteristics of the study population and control subjects
Study population (n = 364) Control (n = 93) P-value
Characteristics Mean (± SD) Mean (± SD)
Age (years) 66.2 ± 10.2 65.3 ± 7.1 0.417
Male, n (%) 233 (64%) 49 (53%) 0.056
BMI (kg/m2) 24.99 ± 3.30 23.80 ± 3.40 0.002*
Waist-to-hip ratio 0.93 ± 0.06 0.91 ± 0.08 <0.001*
Ischemic stroke, n (%) 49 (13.46) ---- <0.001*
Coronary artery disease, n (%) 224 (61.54) ---- <0.001*
Diabetes mellitus, n (%) 200 (54.95) ---- <0.001*
Hypertension, n (%) 232 (63.74) 22 (23.66) <0.001*
Hyperlipidaemia, n (%) 232 (63.74) 30 (32.26) <0.001*
Smokers, n (%) 165 (45.33) 14 (15.05) <0.001*
Systolic blood pressure (mmHg) 141.00 ± 19.85 127.82 ± 18.04 <0.001*
Diastolic blood pressure (mmHg) 79.16 ± 9.19 75.06 ± 9.32 <0.001*
Total serum cholesterol (mmol/L) 4.50 ± 0.89 5.12 ± 0.83 <0.001*
Serum HDL-C (mmol/L) 1.28 ± 0.34 1.48 ± 0.40 <0.001*
Serum LDL-C (mmol/L) 2.56 ± 0.72 3.05 ± 0.76 <0.001*
Serum triacylglycerol (mmol/L) 1.49 ± 0.97 1.34 ± 0.74 0.167
Fasting glucose (mmol/L) 6.36 ± 2.07 5.16 ± 0.60 <0.001*
HbA1c (%) 7.05 ± 1.48 6.63 ± 5.33 0.192
Medications
Beta-blocker, n (%) 184 (50.55) 6 (6.5) <0.001*
ACEI/ARB, n (%) 36 (9.9) ----- <0.001*
Statin, n (%) 226 (62.09) 3 (3.2) <0.001*
PWV (cm/s) 1102.17 ± 144.54 1079.48 ± 135.09 0.172

ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; PWV, pulse wave velocity.; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol.

*p-value <0.05.

Chan et al.

Chan et al. BMC Cardiovascular Disorders 2014 14:24   doi:10.1186/1471-2261-14-24

Open Data